We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q1 Potential of Nordson (NDSN): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Nordson (NDSN - Free Report) will announce quarterly earnings of $2.08 per share in its forthcoming report, representing a decline of 5.9% year over year. Revenues are projected to reach $636.33 million, increasing 0.5% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Nordson metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts forecast 'Net Sales- Industrial Precision Solutions' to reach $323.59 million. The estimate indicates a change of -8.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Net Sales- Advanced Technology Solutions' should come in at $120.25 million. The estimate points to a change of +1% from the year-ago quarter.
Analysts expect 'Net Sales- Medical and Fluid Solutions' to come in at $195.02 million. The estimate suggests a change of +22.3% year over year.
The average prediction of analysts places 'Operating profit (loss)- Advanced Technology Solutions' at $22.94 million. Compared to the present estimate, the company reported $19.04 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Operating profit (loss)- Medical and Fluid Solutions' of $52.08 million. The estimate is in contrast to the year-ago figure of $46.10 million.
It is projected by analysts that the 'Operating profit (loss)- Industrial Precision Solutions' will reach $97.25 million. The estimate compares to the year-ago value of $108.36 million.
Over the past month, Nordson shares have remained unchanged versus the Zacks S&P 500 composite's +4.7% change. Based on its Zacks Rank #4 (Sell), NDSN will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unlocking Q1 Potential of Nordson (NDSN): Exploring Wall Street Estimates for Key Metrics
Analysts on Wall Street project that Nordson (NDSN - Free Report) will announce quarterly earnings of $2.08 per share in its forthcoming report, representing a decline of 5.9% year over year. Revenues are projected to reach $636.33 million, increasing 0.5% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Nordson metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts forecast 'Net Sales- Industrial Precision Solutions' to reach $323.59 million. The estimate indicates a change of -8.7% from the prior-year quarter.
According to the collective judgment of analysts, 'Net Sales- Advanced Technology Solutions' should come in at $120.25 million. The estimate points to a change of +1% from the year-ago quarter.
Analysts expect 'Net Sales- Medical and Fluid Solutions' to come in at $195.02 million. The estimate suggests a change of +22.3% year over year.
The average prediction of analysts places 'Operating profit (loss)- Advanced Technology Solutions' at $22.94 million. Compared to the present estimate, the company reported $19.04 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Operating profit (loss)- Medical and Fluid Solutions' of $52.08 million. The estimate is in contrast to the year-ago figure of $46.10 million.
It is projected by analysts that the 'Operating profit (loss)- Industrial Precision Solutions' will reach $97.25 million. The estimate compares to the year-ago value of $108.36 million.
View all Key Company Metrics for Nordson here>>>
Over the past month, Nordson shares have remained unchanged versus the Zacks S&P 500 composite's +4.7% change. Based on its Zacks Rank #4 (Sell), NDSN will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>